-
National organizations filed amicus briefs in two federal cases centered on a law enacted in Washington, DC.
-
For patients and families, a combination ED-ICU means avoiding costly ICU admissions that do not align with care goals. For health systems, it means alleviating ICU capacity strain.
-
Ninety percent of 585 of board-certified healthcare chaplains said advance care planning is important to their work, 70% regularly help patients complete paperwork after discussions, 90% facilitate discussions with patients about their preferences, and 45% reported they were not consistently included in team discussions on decision-making.
-
Researchers were surprised that despite ongoing efforts to develop research ethics programs over many years in the United States and internationally, there was no published competency framework to follow, nor was there a standard approach to creating competencies in this context. This, despite the fact competencies have been used for education in business, medicine, and elsewhere for decades.
-
A survey of current and former egg donors revealed some possible gaps when it comes to communicating potential long-term risks.
-
Adolescents and their parents are interested in taking the COVID-19 vaccine; more education and other developments could sway even more, according to the results of a survey. Respondents indicated more information on safety and efficacy for adolescents was one of the top factors that would increase the likelihood of taking the vaccine. They also said primary care providers and health officials were their most trusted sources for vaccine information.
-
Parental rights issues often are asserted, but at the same time, society has a stake in protecting children from harm, including medical neglect.
-
Beyond the ethical questions, there are logistics, privacy, and even equity concerns to consider.
-
Interest in clinical research on cannabis and psilocybin is soaring. However, current barriers to studying these controlled substances raise ethical questions.
-
Differences in outcomes and responses to treatment in diverse populations often have been attributed to biological factors. However, standardized treatment can tell a divergent story, one in which parameters, such as geographic location and financial status, play a significant role in how a person responds. This underscores the importance of a diverse study population in clinical trials, researchers say.
